Ken Griffin Cytek Biosciences, Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$5.3 - $6.91 $530 - $691	100 New	100 $0
Q3 2023 Nov 14, 2023	BUY	$5.52 - $9.5 $31,463 - $54,150	5,700 Added 158.33%	9,300 $51,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $23,415 - $41,965	3,500 Added 3500.0%	3,600 $30,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $1,688 - $2,694	-200 Reduced 66.67%	100 $0
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $2,913 - $4,758	300 New	300 $3,000

129

74.7M

200

100

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $681M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.